No Data
No Data
Abterra^ Medical (301097.SZ): Signed the "Equity Entrustment Management Agreement".
On March 6, Gelonghui reported that Abterra^ Medical (301097.SZ) announced that the company recently signed a "Shareholder Entrustment Management Agreement" with the company's controlling shareholder and actual controller Wu Zhimin, Wu Bin, and the Ningbo Tianhuiyi Enterprise Management Limited Liability Company (referred to as "Ningbo Tianhuiyi") controlled by them. Wu Zhimin and Wu Bin agreed to entrust the shares they directly or indirectly hold through Ningbo Tianhuiyi in nichijizō (Shanghai) Industrial Co., Ltd. (referred to as "NMS"), Nikkiso Europe GmbH (referred to as "NEG"), Thorvard Medical (Thailand).
Tianyi Medical Appliance to Buy Bellco's CRRT Business Assets for 12 Million Euros
Abterra^ Medical (301097.SZ): The subsidiary intends to acquire assets related to the CRRT-filter business.
On February 14, Glonghui reported that Abterra^ Medical (301097.SZ) announced that the Board of Directors approved the acquisition of the CRRT-filter business assets from BELLCOS R.L. (referred to as "the Seller") through its wholly-owned subsidiary in Singapore, PRIMACRON GLOBAL PTE. LTD. (referred to as "PRIMACRON" or "the Buyer"). The company plans to acquire the Seller's CRRT-filter business assets for Cash, with the expected transaction price of 11.99 million euros, funded by the company's own funds and possibly supplemented by Banks loans. To achieve this...
Abterra^ Medical (301097.SZ): New product has obtained the product registration certificate.
On February 10, Gelonghui reported that Abterra^ Medical (301097.SZ) announced that the company recently received the "Medical Instruments Registration Certificate" issued by the Zhejiang Provincial Drug Administration for a disposable iodine micro-cover.
Abterra^ Medical (301097.SZ): A total of 2.42% of shares have been repurchased, and the repurchase plan has been completed.
On February 7, Gelonghui reported that Abterra^ Medical (301097.SZ) announced that as of the date of this notice, the company has repurchased a total of 1,427,400 shares through the Shenzhen Stock Exchange's stock trading system via centralized auction trading, accounting for 2.42% of the company's total share capital, with a maximum Fill Price of 42.80 yuan/share, a minimum Fill Price of 32.71 yuan/share, and a total transaction amount of 57,641,335.95 yuan (excluding stamp tax, transaction commission, and other transaction costs). The actual repurchase time Range for this stock repurchase is from February 8, 2024, to February 7, 2025.
Tianyi Healthcare: 2024 Annual Performance Forecast